Iambic and Takeda strike $1.7B AI deal for drug discovery

AI drug discovery company Iambic struck a new collaboration with Takeda worth about $1.7 billion, the companies announced Monday.

Why it matters: Large drugmakers are increasingly betting on AI platforms to accelerate and de-risk early-stage drug discovery.